An Observational Study of People Who Have Recently Been Infected With HIV
Completed
Conditions studied: HIV Infections
In brief
This is a long-term follow-up study of people who are identified during acute or recent HIV infection and are being followed at clinical research sites associated with the Acute HIV Infection and Early Disease Research Program (AIEDRP). The purpose of this study is to collect data on the immunological and virologic responses that occur early in the course of HIV infection in treatment-naive and treatment-experienced HIV infected adults. Study hypothesis: This study will examine the immunological responses that occur early in the course of HIV infection in treated and untreated individuals. The long-term follow-up of these subjects will help identify host immunological and genetic factors along with therapeutic strategies associated with control of viremia and delayed disease progression. In addition, this cohort will provide the recruiting mechanism to support future trials of therapy to restore immune function. Furthermore, this cohort will provide a population suitable to monitoring changing patterns in the transmission of drug resistant viral strains while also evaluating ongoing behavioral risk factors associated with HIV transmission.
Key facts
- Study ID
- NCT00103961
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 500
- Starts
- 2004-01-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2018-11-28
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documented acute or recent HIV infection as defined in the study protocol
- Willing to be followed longitudinally by this study
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham & Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.